Agave Dream Cappuccino Ice Cream Recall Issued Due to Listeria Poisoning Risk

Nearly 400 cases of ice cream have been recalled by federal safety officials due to the risk of listeria food poisoning, a serious and sometimes fatal foodborne infection. 

An Agave Dream Cappuccino ice cream recall was announced by the FDA on July 19, after routine testing by Washington health officials identified the presence of listeria. To date no illnesses have been reported.

The recall includes an estimated 389 cases of Agave Dream Cappuccino ice cream pints with UPC code 899349002048. The recalled pints were sold in a brown paper pint sized container and have the brand name “Agave Dream” printed on the front of the carton with a “Best By” date of July 4, 2017 displayed as “07/04/17”.

Do You Know About...

Childhood Diabetes Lawsuits Against Junk Food Industry

Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods.

Learn More

According to the FDA release, no illnesses have been reported and the manufacturer has ceased the production and distribution of the products pending an investigation to discover the source of the contamination.

Listerosis is a foodborne illness that can cause serious health consequences and death, especially for children, the elderly and those with weakened immune systems. The infection is considered by the FDA as one of the more dangerous foodborne illnesses and frequently results in hospitalizations and carries a 25% fatality rate.

Symptoms of listeria infections may include nausea, muscle ache, diarrhea, fever, and fatigue. In severe cases for the elderly and young children, the bacteria could spread through the bloodstream to the nervous system resulting in sometimes fatal infections. For pregnant women, listerosis can pose a risk of miscarriages, still births, premature delivery or life-threatening infection of the newborn.

The recalled ice cream products were manufactured by Agave Dream of Verdes Peninsula, California and distributed across the nation to various retailers from KeHE Romeoville, Illinois warehouse, DPI NW Americold ware house in Louisiana, IWI Franklin Indiana warehouse, and Haddon House Richburg of South Carolina.

The FDA recommends that customers with recalled Agave Dream Cappuccino ice cream products containing “Best By” date “07/04/17” stop consuming them immediately and contact the manufacturer at 866-993-4438 or email them at agavedream@sbcglobal.net for information on how to receive a full refund.

A similar recall was issued last year in May, when the FDA forced a recall of all of Blue Bell Creameries products out on store shelves following 10 illnesses and three deaths and linked to strains of listeria traced back to their products.

According to documents filed by the Department of Health and Human Services (DHHS) the company knew of existing contamination problems at its Oklahoma plant since 2013, when the FDA collected 17 positive tests for listeria on equipment and around its plant from March 2013 through February 2015. Additional reports indicated Blue Bell sent “presumptive positive” listeria samples to a third party for confirmation on at least two occasions in 2014.

As a result of the potential cover-up scandal, a complaint was filed against Blue Bell Creameries in May 2015 by 32 year old David Philip Shockley, who indicates that he worked as an administrator in a retirement community in Houston when he ate contaminated ice cream in October 2013 and fell ill.

Shockley alleges that he contracted a severe case of listeria meningitis with encephalitis from the ice cream, which resulted in respiratory failure, septic shock and brain damage. He is now unable to work and is cared for by his parents in Maryland.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program
Judge Indicates 40 Hair Relaxer Lawsuits Over Uterine Cancer, Endometrial Cancer and Ovarian Cancer Will Be Selected for Early Trial Program (Posted today)

A federal judge has ordered plaintiffs and defendants involved in hair relaxer cancer litigation to select 20 cases each, for a total of 40, to undergo case-specific discovery to prepare them to serve as potential bellwether trials.

New Port Catheter Lawsuits Against AngioDynamics Can Now Be Directly Filed in Federal MDL
New Port Catheter Lawsuits Against AngioDynamics Can Now Be Directly Filed in Federal MDL (Posted 3 days ago)

A federal judge has approved the direct filing of AngioDynamics port catheter lawsuits in the U.S. District Court for the District of Southern California, where the litigation has been centralized for coordinated discovery and pretrial proceedings.

MDL Panel To Consider Depo-Provera Brain Tumor Lawsuit Consolidation at Hearing Today
MDL Panel To Consider Depo-Provera Brain Tumor Lawsuit Consolidation at Hearing Today (Posted 4 days ago)

The U.S. JPML will hear oral arguments today over the potential creation of a Depo-Provera brain tumor lawsuit multidistrict litigation, which would place all of the federal cases under one judge for coordinated pretrial proceedings.